So grateful to do this work - we asked the question "How can we design systems to make us better diagnosticians over time?" We looked outside medicine and found some important ideas... (1/n)
Large database study showed no difference in the rate of cerebrovascular disease, myocardial infarction, major bleeding, or hospitalization following intravitreal injections of bevacizumab, ranibizumab, or aflibercept for retinal conditions https://t.co/mBRJqJdRKZ
In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, preventive treatment did not confer visual acuity benefit compared with observation plus aflibercept if complications developed https://t.co/q4ABSKOMVj
You know @BHooperMD gave a great talk on managing your online presence when lots of @EVMSedu friends find their way to Twitter!
Go follow my brilliant friends @DBarmasMD and @HaleyDSouzaMD!! They’re both about to start Ophtho training 👀👏🏻